Topics

Articles

The commission is launching a broad review of drug-company mergers to explore how such deals can potentially harm industry competition  

FTC eyes crackdown on pharma mergers

While clock now ticking for life sciences companies to comply with the new data standards, opportunities in the offing to simplify manufacturing and the supply chain   

EMA launches IDMP Implementation Guide 

Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another

Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patenting

Go-to safeguards for manufacturers in avoiding mismanagement of their business-central records

Effective and proactive oversight of master data

Building in the right processes and support for data quality, standards, and governance

Data as a strategic asset in the life sciences

Report on member-distributor performance metrics for 2019

HDA foundation captures specialty Rx distributor trends

Decision a win for independent pharmacies in claim of PBM abuse of power

High Court rules that states can regulate PBMs

Illustrates that majority of pharma sales were made through organization’s traditional distributor network

Latest HDA Factbook outlines supply chain trends

Actions manufacturers can build into their regulatory planning as UK nears new regime

Med device task guide for UK conformity post-Brexit

Granted purchase rights to Adents' assets in likely benefit for supply-chain transparency efforts

Legal and Regulatory